A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures
- PMID: 22143005
- PMCID: PMC3317062
- DOI: 10.1038/mp.2011.165
A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures
Abstract
Recent studies have implicated physiological and metabolic abnormalities in autism spectrum disorders (ASD) and other psychiatric disorders, particularly immune dysregulation or inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures ('four major areas'). The aim of this study was to determine trends in the literature on these topics with respect to ASD. A comprehensive literature search from 1971 to 2010 was performed in these four major areas in ASD with three objectives. First, publications were divided by several criteria, including whether or not they implicated an association between the physiological abnormality and ASD. A large percentage of publications implicated an association between ASD and immune dysregulation/inflammation (416 out of 437 publications, 95%), oxidative stress (all 115), mitochondrial dysfunction (145 of 153, 95%) and toxicant exposures (170 of 190, 89%). Second, the strength of evidence for publications in each area was computed using a validated scale. The strongest evidence was for immune dysregulation/inflammation and oxidative stress, followed by toxicant exposures and mitochondrial dysfunction. In all areas, at least 45% of the publications were rated as providing strong evidence for an association between the physiological abnormalities and ASD. Third, the time trends in the four major areas were compared with trends in neuroimaging, neuropathology, theory of mind and genetics ('four comparison areas'). The number of publications per 5-year block in all eight areas was calculated in order to identify significant changes in trends. Prior to 1986, only 12 publications were identified in the four major areas and 51 in the four comparison areas (42 for genetics). For each 5-year period, the total number of publications in the eight combined areas increased progressively. Most publications (552 of 895, 62%) in the four major areas were published in the last 5 years (2006-2010). Evaluation of trends between the four major areas and the four comparison areas demonstrated that the largest relative growth was in immune dysregulation/inflammation, oxidative stress, toxicant exposures, genetics and neuroimaging. Research on mitochondrial dysfunction started growing in the last 5 years. Theory of mind and neuropathology research has declined in recent years. Although most publications implicated an association between the four major areas and ASD, publication bias may have led to an overestimation of this association. Further research into these physiological areas may provide insight into general or subset-specific processes that could contribute to the development of ASD and other psychiatric disorders.
Figures

Similar articles
-
Redox metabolism abnormalities in autistic children associated with mitochondrial disease.Transl Psychiatry. 2013 Jun 18;3(6):e273. doi: 10.1038/tp.2013.51. Transl Psychiatry. 2013. PMID: 23778583 Free PMC article.
-
Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder.Altern Med Rev. 2010 Apr;15(1):15-32. Altern Med Rev. 2010. PMID: 20359266 Review.
-
Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.Transl Psychiatry. 2013 Jan 22;3(1):e220. doi: 10.1038/tp.2012.143. Transl Psychiatry. 2013. PMID: 23340503 Free PMC article.
-
Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD).Cerebellum. 2011 Mar;10(1):43-8. doi: 10.1007/s12311-010-0223-4. Cerebellum. 2011. PMID: 20967576
-
Targeted Biomedical Treatment for Autism Spectrum Disorders.Curr Pharm Des. 2019;25(41):4430-4453. doi: 10.2174/1381612825666191205091312. Curr Pharm Des. 2019. PMID: 31801452 Review.
Cited by
-
Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems.J Am Acad Child Adolesc Psychiatry. 2012 Jul;51(7):712-721.e1. doi: 10.1016/j.jaac.2012.04.010. Epub 2012 May 26. J Am Acad Child Adolesc Psychiatry. 2012. PMID: 22721594 Free PMC article.
-
Potential Role of L-Carnitine in Autism Spectrum Disorder.J Clin Med. 2021 Mar 13;10(6):1202. doi: 10.3390/jcm10061202. J Clin Med. 2021. PMID: 33805796 Free PMC article. Review.
-
Blood RNA Sequencing Indicates Upregulated BATF2 and LY6E and Downregulated ISG15 and MT2A Expression in Children with Autism Spectrum Disorder.Int J Mol Sci. 2022 Aug 30;23(17):9843. doi: 10.3390/ijms23179843. Int J Mol Sci. 2022. PMID: 36077244 Free PMC article.
-
Behaviorally associated changes in neuroconnectivity following autologous umbilical cord blood infusion in young children with autism spectrum disorder.Ann Transl Med. 2019 Jul;7(Suppl 3):S123. doi: 10.21037/atm.2019.05.55. Ann Transl Med. 2019. PMID: 31576330 Free PMC article. No abstract available.
-
Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.Mol Diagn Ther. 2018 Oct;22(5):571-593. doi: 10.1007/s40291-018-0352-x. Mol Diagn Ther. 2018. PMID: 30039193 Free PMC article. Review.
References
-
- APA Diagnostic and Statistical Manual of Mental Disorders4th edn.American Psychiatric Association: Washington, DC; 1994
-
- Rice C. Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ. 2009;58:1–20. - PubMed
-
- Schaefer GB, Mendelsohn NJ. Genetics evaluation for the etiologic diagnosis of autism spectrum disorders. Genet Med. 2008;10:4–12. - PubMed
-
- Buie T, Campbell DB, Fuchs GJ, III, Furuta GT, Levy J, Vandewater J, et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics. 2010;125 (Suppl 1:S1–18. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical